Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cyc-dezocine is a novel formulation of dezocine being investigated as a therapeutic for opioid use disorder. Based on the provided preclinical publication, it is designed for intraperitoneal or intranasal administration and reduced oxycodone self-administration in male and female rat models. Dezocine is an opioid analgesic with partial agonist activity at the mu opioid receptor and pharmacology involving the kappa opioid receptor; cyc-dezocine appears to leverage this opioid receptor activity in a reformulated product intended to decrease voluntary opioid intake rather than to serve as a conventional perioperative analgesic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyc-dezocine.